CANADA LIFE ASSURANCE Co
InsurancePosition in RCUS — Arcus Biosciences, Inc.
CIK 1046192
WINNIPEG, A2
Position in RCUS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,523,188
-$236,943 QoQ
Shares Held
70,518
-4.5% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $291,124,718 across 78 Biotechnology names. RCUS ranks #27 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
192,144 | $85,799,981 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,886 | $60,950,479 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,255 | $18,943,961 | |
| 4 | INCY |
Incyte Corp
|
111,609 | $10,504,639 | |
| 5 | INSM |
INSMED Inc
|
53,890 | $8,812,092 | |
| 6 | ARGX |
Argenx SE
|
11,567 | $8,446,801 | |
| 7 | MRNA |
Moderna, Inc.
|
148,181 | $7,527,594 | |
| 8 | EXEL |
Exelixis, Inc.
|
167,451 | $7,181,973 |
All Filings in RCUS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,523,188 | 70,518 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,760,131 | 73,862 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $805,827 | 59,252 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $482,311 | 59,252 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $409,377 | 52,150 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $776,513 | 52,150 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $797,373 | 52,150 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $896,315 | 58,852 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $876,522 | 46,426 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $886,736 | 46,426 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $833,346 | 46,426 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $923,983 | 45,494 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $888,889 | 48,733 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,095,109 | 52,955 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,484,658 | 56,753 | Shares | Sole | 2022-11-01 | |
| 2022-03-31 | $57,312 | 1,816 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $101,579 | 2,510 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $87,523 | 2,510 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $68,924 | 2,510 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $70,480 | 2,510 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $92,183 | 3,551 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $28,795 | 1,680 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $41,563 | 1,680 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $5,940 | 428 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||